B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct - PubMed (original) (raw)

. 1996 Feb 1;156(3):1126-31.

Affiliations

PMID: 8557988

B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct

U Matulonis et al. J Immunol. 1996.

Abstract

Although intact, viable tumor cells rarely induce a clinically significant immune response in vivo, immunogenicity can be elicited by irradiated tumor cells that protect against subsequent challenge with wild-type intact viable tumor cells. Genetic modification of murine tumor cells, by transfection of cDNAs encoding either cytokines, MHC molecules, or costimulatory molecules, has been capable of inducing antitumor immunity. We and others have previously demonstrated that expression of the B7-1 costimulatory molecule, in either immunogenic or nonimmunogenic tumors, can protect against subsequent challenge with wild-type tumor cells. In this work, using a murine model of acute myeloid leukemia, we demonstrate that the B7-1 costimulatory molecule is superior to the B7-2 molecule in its capacity to protect against wild-type tumor challenge and eradicate minimal residual disease. These results provide compelling evidence that the B7-1 and B7-2 costimulatory signals are functionally distinct, thus resulting in clinically significant differences in the induction of antitumor immunity in vivo.

PubMed Disclaimer

Cited by

Soluble CD86 protein in serum samples of patients with asthma.
Shi HZ, Xie ZF, Deng JM, Chen YQ, Xiao CQ. Shi HZ, et al. Thorax. 2004 Oct;59(10):870-5. doi: 10.1136/thx.2004.021840. Thorax. 2004. PMID: 15454653 Free PMC article.
Modulation of experimental blood stage malaria through blockade of the B7/CD28 T-cell costimulatory pathway.
Taylor-Robinson AW, Smith EC. Taylor-Robinson AW, et al. Immunology. 1999 Mar;96(3):498-504. doi: 10.1046/j.1365-2567.1999.00718.x. Immunology. 1999. PMID: 10233733 Free PMC article.
Mechanisms of ganglioside inhibition of APC function.
Caldwell S, Heitger A, Shen W, Liu Y, Taylor B, Ladisch S. Caldwell S, et al. J Immunol. 2003 Aug 15;171(4):1676-83. doi: 10.4049/jimmunol.171.4.1676. J Immunol. 2003. PMID: 12902465 Free PMC article.
Immunotherapy III: Combinatorial molecular immunotherapy--a synthesis and suggestions.
Vile RG, Chong H. Vile RG, et al. Cancer Metastasis Rev. 1996 Sep;15(3):351-64. doi: 10.1007/BF00046347. Cancer Metastasis Rev. 1996. PMID: 9034596 Review.
A simian virus 5 (SV5) P/V mutant is less cytopathic than wild-type SV5 in human dendritic cells and is a more effective activator of dendritic cell maturation and function.
Arimilli S, Alexander-Miller MA, Parks GD. Arimilli S, et al. J Virol. 2006 Apr;80(7):3416-27. doi: 10.1128/JVI.80.7.3416-3427.2006. J Virol. 2006. PMID: 16537609 Free PMC article.

B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct - PubMed (original) (raw)